6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 15 Oct 2025
- Reporting date
- 15 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
GSK plc reports
- Company location
- London
GSK plc has filed 6,801 SEC EDGAR filings since 12 Jan 2001
SEC filing history
Showing 276-300 of 1,000 matching filings.
Per page
25
Current page
12
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 15 Oct 2025
- Reporting date
- 15 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK RECEIVES EXPANDED SHINGRIX APPROVAL IN CHINA
- Filing date
- 14 Oct 2025
- Reporting date
- 14 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 14 Oct 2025
- Reporting date
- 14 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 14 Oct 2025
- Reporting date
- 14 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 14 Oct 2025
- Reporting date
- 14 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 10 Oct 2025
- Reporting date
- 10 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 10 Oct 2025
- Reporting date
- 10 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 09 Oct 2025
- Reporting date
- 09 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 08 Oct 2025
- Reporting date
- 08 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 07 Oct 2025
- Reporting date
- 07 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 06 Oct 2025
- Reporting date
- 06 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 03 Oct 2025
- Reporting date
- 03 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 02 Oct 2025
- Reporting date
- 02 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TOTAL VOTING RIGHTS
- Filing date
- 01 Oct 2025
- Reporting date
- 01 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 01 Oct 2025
- Reporting date
- 01 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK - THIRD TRANCHE OF SHARE BUYBACK PROGRAMME
- Filing date
- 30 Sep 2025
- Reporting date
- 30 Sep 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK APPOINTS CEO DESIGNATE
- Filing date
- 29 Sep 2025
- Reporting date
- 29 Sep 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 22 Sep 2025
- Reporting date
- 22 Sep 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 19 Sep 2025
- Reporting date
- 19 Sep 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 18 Sep 2025
- Reporting date
- 18 Sep 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK US INVESTMENT ANNOUNCEMENT
- Filing date
- 17 Sep 2025
- Reporting date
- 17 Sep 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 17 Sep 2025
- Reporting date
- 17 Sep 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 16 Sep 2025
- Reporting date
- 16 Sep 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 15 Sep 2025
- Reporting date
- 15 Sep 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing